Clinical Trial Update: Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing everolimus-based versus calcineurin inhibitor-based immunosuppression in de novo kidney transplant recipients evaluated progression of r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Interstitial Fibrosis

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Everolimus (everolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Renal Interstitial Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2014-03-18